To elucidate the mechanism of anti-lipolytic action of insulin in rat epididymal adipocytes, we explored the potential Ž . mechanism that might be involved in the hormone-dependent stimulation of cAMP phosphodiesterase PDE kinase. PDE kinase was assayed in a cell-free system. Both wortmannin and LY294002, highly specific inhibitors of phosphatidylinositol 3-kinase, almost completely blocked the hormonal effect not only on PDE kinase but also on mitogen-activated protein Ž . MAP kinase. Neither PD98059, a specific inhibitor of MAP kinase, nor rapamycin, a potent inhibitor of insulin-dependent Ž S6K . stimulation of p70 ribosomal protein S6 kinase p70
Introduction
Anti-lipolysis is a major metabolic effect of insulin involving dephosphorylation and concomitant deactiw x vation of hormone-sensitive lipase 1 . Based on their w x studies with inhibitors, Makino et al. 2 and Elks and w x Manganiello 3 concluded that insulin-dependent Ž . stimulation of cAMP phosphodiesterase PDE induced a decline in the cellular level of cAMP and caused dephosphorylation of the lipase, resulting in anti-lipolysis. It was shown earlier that insulin reduces cAMP concentration in the liver and adipocytes w by stimulating a membrane-bound, low-K PDE 4-m x 6 . This PDE appears to be stimulated by insulin as a result of phosphorylation. This view was initially put forth on the basis of the observations that the same, membrane-bound PDE is activated by both insulin ( )w x and isoproterenol or cAMP 7-9 . Subsequently, w x Degerman et al. 10 reported that insulin stimulates phosphorylation of PDE in intact adipocytes at cerw x w x tain serine residues 11 . Shibata et al. 12 found that PDE is stimulated by the incubation of cells with okadaic acid, a potent phosphatase inhibitor. More w x recently, Smith et al. 13 presented their preliminary data, indicating that the cytosol fraction extracted from insulin-treated rat liver induces phosphorylation of PDE in a cell-free system. These earlier studies imply that PDE is phosphorylated by an insulinstimulated PDE kinase, although the latter is yet to be isolated.
Until recently, the above anti-lipolytic mechanism was generally thought to be localized downstream of Ž . phosphatidylinositol 3-kinase PI 3-kinase in the cascade of insulin action since a low concentration of wortmannin, a highly specific inhibitor of PI 3-kinase w x 14 , strongly inhibits hormonal effects on lipolysis w x w x 14 , PDE and PDE kinase 15 . Wortmannin also inhibits the activation of MAP kinase pathway by w x w x insulin 16-18 and Cross et al. 16 suggested that a site of action of wortmannin might be found between Ras and Raf in the upper stream of MAP kinase. This view was recently challenged, however, by the observations that this kinase, according to Cheatham et al. w x 19 , does not appear to lie downstream of PI 3-kinase. Therefore, it is not clear at present if the anti-lipolytic mechanism is localized downstream of PI 3-kinase or MAP kinase.
In our present study, we first established the method of cell-free assay of PDE kinase from rat epididymal adipocytes; subsequently, we investigated Ž .
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i how PDE kinase, MAP kinase and p70 might be localized in the cascade of insulin action in Ž . adipocytes, and ii which protein kinase or kinases might be considered to exist in the upper stream of PDE and PDE kinase.
Experimental procedures

Materials
A preparation of polyclonal antibodies of PDE Ž rabbit serum, referred to as anti-PDE antibody in this . report was custom-made at Japan Immuno Research Ž . Laboratories Takasaki, Japan against a synthetic peptide referred to as PDE peptide, LHNNHETET-KADSDARL. 
Assay of the membrane-bound PDE from rat adipocytes
Isolated adipocytes were prepared by the collagenase method from epididymal fat pads of 200-250 g w x male Sprague-Dawley rats 22 . The cells were incubated without or with 1 nM insulin for 10 min at 378C in Krebs-Ringer-Hepes-Albumin buffer pH Ž . 7.4 KRHA containing 20 mgrml bovine serum albumin and 200 nM adenosine. After the incubation with insulin, adipocytes were washed twice with Ž buffer A 10 mM TES, pH 7.0, containing 250 mM . sucrose and homogenized with a Dounce tissue Ž . grinder eight strokes in the same buffer at room temperature. The membrane-bound fraction obtained w x from isolated adipocytes as described previously 6,9 was suspended in buffer A, pH 7.4, and the PDE w x activity was determined 6,9 . In experiments with inhibitors, cells were preincubated with wortmannin for 20 min, LY294002 for 20 min, rapamycin for 20 ( )min or PD98059 for 30 min before the addition of insulin.
Immunoblotting of PDE
The membrane-bound fraction obtained from isow x lated adipocytes as described previously 6,9 was subjected to SDS-PAGE. Thereafter, proteins were transferred to nitrocellulose and immunoblotted with either anti-PDE antibody or an aliquot of the antibody preparation that had been neutralized by preincubation with the antigenic PDE peptide. Proteins were visualized by the ECL system.
PDE phosphorylation in 32 P-labeled adipocytes
The isolated adipocytes were incubated with w 32 x Ž . P orthophosphate 50 mCirml for 90 min at 378C in KRHA buffer pH 7.4 without inorganic phosphate containing 200 nM adenosine, 2 mM glucose, and 20 mgrml bovine serum albumin. In the experiment of wortmannin, the adipocytes were pretreated with wortmannin for 20 min prior to treatment of insulin. After 10 min incubation with 1 nM insulin, adipocytes were washed twice with buffer A and homogenized in the same buffer containing 0.1 mM calyculin A, 50 mM paranitrophenylphosphate, 0.5 mM phenylmethylsulfonyl fluoride, 15 mgrml leupeptin, 15 Ž . mgrml pepstatin A, 3 mM benzamidine buffer B at room temperature. Then homogenates were immedi-Ž ately cooled to 48C and centrifuged 100 000 = g, 30 . min, 48C . The membrane-bound fractions were solubilized with 1% Triton X-100 in buffer B. After 1 h, Ž solubilized proteins were centrifuged 100 000 = g, 1 . h, 48C and supernatants were immunoprecipitated with anti-PDE antibody. To minimize non-specific precipitation of proteins, supernatants were preincubated with protein G for 20 min at 48C and then incubated with anti-PDE antibody overnight at 48C. The immune complexes were precipitated by protein G and collected by centrifugation. Immunoprecipitated proteins were washed with 1% TritonX-100, 0.1% SDS and 0.1% TritonX-100, 0.1% SDS in 50 mM Hepes pH 7.5 two times each and subjected to SDS-PAGE in 7.5% gels. The gels were dried and autoradiographed with intensifying screen at y708C on Kodak X-Omat AR film or visualized with digital imaging of Fujix BAS 2000II.
Phosphorylation of PDE in a cell free system ( ) PDE kinase assay
The PDE kinase assay was performed basically as w x described by Rahn et al. 15 with certain modifications. Adipocytes were homogenized in buffer C Ž buffer A supplemented with 0.2 mM EGTA, 2 mM EDTA, 0.1 mM sodium orthovanadate, 0.1 mM calyculin A, 50 mM paranitrophenylphosphate, 0.5 mM phenylmethylsulfonyl fluoride, 15 mgrml leupeptin, . 15 mgrml pepstatin A and 3 mM benzamidine and Ž . centrifuged 100 000 = g, 60 min, 48C . The membrane-bound fraction obtained was solubilized with Ž 1% Triton X-100 in buffer D buffer A supplemented with 5 mM MgCl , 1 mM EDTA, 0.5 mM phenyl-2 methylsulfonyl fluoride, 15 mgrml leupeptin, 15 . mgrml pepstatin A and 3 mM benzamidine and Ž . centrifuged 100 000 = g, 60 min, 48C . The super-Ž . natant fraction solubilized PDE preparation was Ž used as the substrate in the PDE kinase assay see . below . For preparation of PDE kinase, adipocytes incubated without or with 1 nM insulin for 10 min were washed and homogenized in buffer C. In the experiment of EGF or IGF-I, the incubation period Ž was for 5 min. The supernatant fraction 100 000 = g, . 60 min, 48C was used as the PDE kinase preparation Ž . in the assay see below . For the cell-free assay of PDE kinase, the kinase preparation was incubated with the solubilized PDE preparation in the presence Ž of the ATP mixture 600 mM Hepes, pH 7.5, 10 mM w 32 x MgCl , 0.3 mM EGTA, 210 mM g-P ATP, and 6 2 . mM H-89 for 20 min at 308C. In the experiment of direct effect of wortmannin, Ly294002, heparin, H-7, CKI-7 and CaCl on PDE kinase, each inhibitor was 2 added to the kinase preparation prior to the reaction. The reaction was terminated by the addition of a stop solution. Thereafter, the reaction mixture was treated with anti-PDE antibody, and the immune complexes were precipitated with protein G, collected by centrifugation. The washed immune complexes were subjected to SDS-PAGE and autoradiographed or quantitated with a Fujix BAS 2000II digital analyzer as described above.
Assays of MAP kinase and p70
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Adipocytes were incubated with or without 1 nM insulin, 100 ngrml EGF or 100 nM IGF-I; the ( )incubation period was 5 min in the experiments with MAP kinase and 7 min in those with p70 S6K . The cytosol fraction was prepared as described above, and the kinases were immunoprecipitated by treatment with either anti-MAP kinase antibody or anti-p70 S6K antibody. The immunoprecipitates were washed and resuspended in buffer C. MAP kinase was assayed with the BIOTRAKe MAPK assay kit as described w x
by Ferby et al. 23 , whereas p70 was assayed using the so-called large S6 peptide as substrate as w x described by Lin and Lawrence 24 .
Phenyl sepharose column chromatography of MAP kinase and its assay
An aliquot of the cytosol fraction of adipocytes stimulated with 1 nM insulin was applied to a phenyl Ž . sepharose column 0.7 = 0.5 cm equilibrated with buffer C. The column was then washed batch-wise with the buffer followed by that containing 20 or 40% ethylene glycol. Each fraction was assayed for PDE kinase and MAP kinase.
Results
Immunoblotting of PDE
PDE was detected as a 140-kDa band when the membrane-bound fraction from rat adipocytes was Fig. 1 . Immunoblotting assay of PDE. Membrane-bound fractions from adipocytes were subjected to SDS-PAGE followed by Western blot analysis. The preparations were immunoblotted with Ž . either anti-PDE antibody PDE peptide: y or antibody that had been neutralized by preincubation with the PDE peptide used as Ž . antigen PDE peptide: q . Proteins were visualized by ECL system. Ž . P labeled adipocytes were incubated without y or with q i 1 nM insulin. Solubilized membrane-bound fractions of adipocytes were immunoprecipitated with either anti-PDE anti-Ž . Ž body PDE peptide: y or the neutralized antibody PDE pep-. tide: q and immunoprecipitates were subjected to SDS-PAGE followed by autoradiography.
subjected to SDS-PAGE followed by immunoblotting with anti-PDE antibody that was raised against a specific synthetic peptide, referred to as PDE peptide Ž . see Section 2 . Significantly, no 140-kDa band was detectable when blotting was done with an aliquot of the antibody that had been neutralized by preincuba-Ž . tion with the antigenic PDE peptide Fig. 1 . 
PDE phosphorylation in 32 P-labeled adipocytes
As shown in Fig. 2 , insulin considerably stimulated phosphorylation of the 140-kDa protein in cells incubated with 32 P . We assumed that the 140-kDa i band was that of phosphorylated PDE since it was undetectable when the immunoprecipitation was done with the antibody neutralized with PDE peptide. The molecular mass of PDE estimated by this method was slightly larger than that calculated from the amino w x acid sequence deduced from PDE cDNA 20 . Furthermore, the anti-PDE antibody effectively immunoprecipitated PDE activity from the solubilized membrane-bound fraction, effect of which was completely Ž blocked with the neutralized antibody data not . shown . We concluded, therefore, that the anti-PDE antibody raised for our present study was a valid preparation. 
Effect of wortmannin on insulin-dependent actiÕation and phosphorylation of PDE in rat fat cells
We examined the effect of a specific inhibitor of w x PI 3-kinase 14 , wortmannin on insulin-dependent activation and phosphorylation of PDE in rat fat cells. Phosphorylation of PDE was induced by 1 nM insulin whereas pretreatment of 32 P labeled fat cells with 100 nM wortmannin completely inhibited the Ž . phosphorylation of PDE induced by insulin Fig. 3A .
As for PDE activation, 1 nM insulin activated the PDE about two times and pretreatment of fat cells with 100 nM wortmannin completely inhibited the Ž . insulin-dependent activation of the PDE Fig. 3B . The effective concentration of wortmannin on insulin-induced PDE activation was almost the same as that of the insulin-induced PDE phosphorylation.
Assay of PDE kinase in a cell-free system
By extending the work initiated by Smith et al. w x 13 , we demonstrated the insulin-dependent phosphorylation of PDE in our cell-free system. As shown in Fig. 4A , PDE kinase extracted from insulin-stimulated adipocytes considerably stimulated phosphorylation of the 140-kDa protein, that is, PDE as determined in the experiment shown above. The level of phosphorylation by the kinase extracted from the basal state of adipocytes was very low, and no 140-kDa band was detectable in either basal or plus-in-Ž . Fig. 4 . Cell-free assay of PDE kinase. A PDE kinase activity in the cytosol fraction that had been prepared from basal or insulintreated adipocytes was determined by incubation with the solubiw 32 x lized PDE preparation in the presence of g-P ATP and other agents as described under Section 2. The reaction mixture was Ž . treated with either anti-PDE antibody PDE peptide: y or the Ž . neutralized antibody preparation PDE peptide: q . Immunoprecipitates were subjected to SDS-PAGE followed by autoradiog-Ž . raphy. B The quantity of PDE in solubilized PDE preparation was monitored with immunoblotting before PDE kinase assay. In each lane, equal level of PDE was confirmed.
sulin experiments when immunoprecipitation was done with the neutralized antibody. The quantity of PDE in solubilized PDE preparation was monitored . 4B . These data support the view that the effect of insulin on PDE kinase can be determined in our cell-free system. Although the data are not shown, PDE kinase was deactivated when insulin-treated cells were homogenized in the absence of any phosphatase Ž . inhibitors see Section 2 . It would appear, therefore, that the activated form of PDE kinase was phosphow x rylated, as suggested earlier 25,26 .
Inhibitory effects of wortmannin and LY294002 on insulin-dependent stimulation of PDE kinase
Ž
In confirmation of several previous data see Sec-. tion 4 , insulin-dependent stimulation of PDE kinase was strongly inhibited in the presence of either 100 Ž . nM wortmannin or 100 mM LY294002 Fig. 5A . Ž Ly294002 at 100 mM as well as wortmannin Fig. . 3B inhibited insulin-dependent activation of PDE by Ž . 85 " 6.9% mean " SE, n s 3 . But neither wortmannin nor LY294002 had any direct effect on PDE Ž . kinase itself Fig. 10 .
Inhibitory effects of wortmannin and LY294002 on insulin-dependent stimulation of MAP kinase
The insulin-dependent stimulation of MAP kinase in adipocytes was effectively blocked in the presence Fig. 6 . Effect of PD98059 on the insulin-dependent activation of PDE kinase and MAP kinase. Adipocytes were incubated with Ž . either 0 or 25 mM PD98059 for 30 min and then without y or Ž . Ž . with 1 nM insulin q . A PDE kinase in the cytosol fraction was assayed as described in Fig. 5 . The values are expressed as Ž . mean"SE from three separate experiments. B MAP kinase in the cytosol fraction was assayed as described in Fig. 5 . The values are expressed as mean"SE from three separate experiments.
of either 100 nM wortmannin or 100 mM LY294002 Ž . Ž . Fig. 5B . The concentrations of insulin 1 nM and the inhibitors used in this set of experiments were identical to those used above in Fig. 5A . In all these experiments, the preincubation of cells with the re- 
Differential effects of PD98059 on the insulindependent stimulation of PDE kinase and MAP kinase
To test the possibility that MAP kinase might be involved in the hormone-dependent stimulation of PDE kinase, we tested the effects of PD98059, a w x highly specific inhibitor of MAP kinase 27 , on the insulin-dependent stimulation of PDE kinase and that of MAP kinase. As shown in Fig. 6 , 25 mM PD98059 had little effect on the insulin-dependent stimulation Ž . of PDE kinase Fig. 6A but exhibited a strong Ž . inhibitory effect on that of MAP kinase Fig. 6B . As might be expected, the inhibitor had little effect on Ž the insulin-dependent stimulation of PDE data not . shown . In all these experiments, cells were preincubated with PD98059 for 30 min before the addition Ž . of insulin see Section 4 .
Effect of EGF or IGF-I on PDE kinase or MAP kinase in rat adipocytes
To confirm that MAP kinase is not involved in the stimulation of PDE kinase, we tested the effect of Fig. 7 . Effect of EGF or IGF-I on PDE kinase or MAP kinase. Adipocytes were incubated with 1 nM insulin, 100 ngrml EGF Ž . or 100 nM IGF-I for 5 min. A PDE kinase in the cytosol fraction was assayed as described in Fig. 5 . The values are Ž . expressed as mean"SE from three separate experiments. B MAP kinase in the cytosol fraction was assayed as described in Fig. 5 . The values are expressed as mean"SE from three separate experiments. EGF or IGF-I on PDE kinase or MAP kinase. While 100 ngrml EGF or 100 nM IGF-I increased MAP kinase activity greater than or almost equal level to that of 1 nM insulin, the activation of PDE kinase by EGF or IGF-I is to lesser extent than that by insulin Ž . Fig. 7 . The effect of EGF and IGF-I on PDE is Ž . similar to that on PDE kinase data not shown . These data are consistent with the previous reports w x 24,28,29 .
EÕidence that PDE kinase is distinct from MAP kinase: experiments with a column of phenyl sepharose
As shown in Fig. 8A , when an aliquot of the cytosol fraction from insulin-stimulated adipocytes was applied to a column of phenyl sepharose, the PDE kinase activity appeared in the flow-through fractions. In contrast, the MAP kinase activity was adsorbed and later eluted into 20 and 40% ethylene Ž . glycol solutions Fig. 8B . These results indicate that PDE kinase is distinct from MAP kinase. 
Distinct effects of rapamycin on the insulin actions on PDE kinase and p70
S6K
It has been shown previously that insulin-dependent stimulation of p70 S6K is blocked by both wortw x w x mannin 16,30,31 and rapamycin 24,32 . As shown in Fig. 9A, 25 nM rapamycin had little effect on the insulin-dependent stimulation of PDE kinase, although it had a strong inhibitory effect on that of S6K Ž . p70 Fig. 9B , as reported. As might be expected, rapamycin had no detectable effect on the insulin-de-Ž . pendent stimulation of PDE data not shown .
EÕidence that PDE kinase is distinct from PI 3-kinase and seÕeral other protein kinases
As shown in Fig. 10 , our cell-free tests indicated that PDE kinase was not directly inhibited by 100 nM wortmannin, 100 mM Ly294002, 1 mgrml heparin w x that inhibits casein kinase II 33 , 20 mM H-7 that w x inhibits protein kinase C 34 and insulin-stimulated w x protein kinase 35,36 , 20 mM CKI-7 that inhibits w x casein kinase I 37 , or 5 mM CaCl that inhibits 2 Mn-specific protein kinase and protease-activated kiw x nase 38,39 . These data indicate that PDE kinase is Fig. 9 . Effect of rapamycin on insulin-dependent activation of PDE kinase and p70 S6K . Adipocytes were incubated with either 0 or 25 nM rapamycin for 20 min followed by the indicated Ž . concentrations of insulin. A PDE kinase in the cytosol was assayed as in Fig. 5 . The values are expressed as mean"SE from Ž .
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three separate experiments. B The assay of p70 was done after the kinase was partially purified by immunoprecipitation with anti-p70 S6K antibody. The values are expressed as mean"SE from three separate experiments. Fig. 10 . Direct effect of wortmannin, Ly294002 and protein kinase inhibitors on PDE kinase. Adipocytes were incubated Ž . Ž . without y or with q 1 nM insulin. PDE kinase in the cytosol fraction was assayed in the presence or absence of given concentrations of wortmannin, Ly294002, heparin, H-7, CKI-7 or CaCl . 2 localized downstream of PI 3-kinase but is not PI 3-kinase itself and that PDE kinase is distinct from the protein kinases tested.
Discussion
The PDE molecule belonging to the PDE gene family has a conserved catalytic domain in its Cterminal region and a regulatory domain in its Nw x terminal region 40 . The catalytic domain of the insulin-sensitive PDE has an insertion of 44 amino acids; the presence of this region appears to be specific for enzymes in the cGMP-inhibited PDE gene family and also important for identifying indiw x vidual members of the family 20 . In our present study, we custom-made anti-PDE antibody against a Ž . synthetic peptide PDE peptide having the amino acid sequence specific for the insulin-sensitive adipocyte PDE. w x This possibility was tested by Cheatham et al. 19 in their experiment with LY294002, a highly specific, synthetic inhibitor of PI 3-kinase designed to block w x the ATP binding to the kinase 52 . The result of their experiment was negative; they found that, in 3T3 adipocytes, 100 mM LY294002 had a strong inhibitory effect on the action of insulin on DNA synthesis, glucose transporter translocation and p70 S6K , but no inhibitory effect on the hormonal w x action on MAP kinase 19 . Accordingly, they concluded that MAP kinase and PI 3-kinase may exist in separate branches of the cascade of insulin action. In this connection, by studying the effects of insulin on several enzymes involved in the glycogen synthesis w x in muscle, Cross et al. 16 suggested that wortmannin may block the hormonal action between Ras and Raf in the upper stream of the MAP kinase cascade.
The results of our experiments with wortmannin w x were consistent with those of others 15-18,28 , indicating that the inhibitor at 100 nM almost completely inhibited the hormonal effects on both PDE kinase Ž . and MAP kinase Figs. 3 and 5 . In contrast, our results with LY294002 were different from those of w x Cheatham et al. 19 . Our data indicated that LY294002 at 100 mM almost completely inhibits not only the hormonal action on PDE kinase but also that Ž . on MAP kinase Fig. 5 . These data imply that both PDE kinase and MAP kinase could be localized downstream of PI 3-kinase. The reason why our findings are apparently different from those of w x Cheatham et al. 19 is not immediately clear; however, a significant factor may be that we exposed Ž . cells to the inhibitor for a long period 20 min prior Ž to incubation with a physiological concentration 1 . Ž . nM of insulin see Section 2 .
If it is assumed that PDE kinase and MAP kinase are both localized downstream of PI 3-kinase, the next question is whether insulin-dependent stimulation of PDE kinase is secondary to that of MAP kinase. The answer to this was found to be negative in our experiments with PD98059, a highly specific w x inhibitor of MAP kinase 27,53 . Our results showed that insulin can stimulate PDE kinase even under conditions when the hormonal effect on MAP kinase Ž . is strongly attenuated Fig. 6 , thus providing positive evidence that MAP kinase is not involved in the insulin-dependent stimulation of PDE kinase. The data in Fig. 7 further support this notion.
Likewise, the results of our experiments with rapamycin positively prove that PDE kinase is distinct from p70 S6K , and that the insulin-dependent stimulation of the former is not secondary to that of the latter Ž . S6K Ž Fig. 9 . As mentioned earlier, p70 like PDE . kinase or MAP kinase is thought to be localized downstream of PI 3-kinase, since the hormone-dependent stimulation of p70 S6K is inhibited by wortmanw x nin 30,31 .
The role of MAP kinase in the insulin-dependent stimulation of glycogen synthase is also controverw x sial. As mentioned earlier, Dent et al. 36 reported that the hormonal effect on glycogen synthesis might be mediated by MAP kinase; however, the results of several recent studies indicated that the hormone may stimulate glycogen synthesis without activating MAP w x kinase 27,31,50,53 . These new observations suggest that MAP kinase may not be involved in the insulindependent stimulation of glycogen synthesis, at least in certain cell types. On the other hand, it has been well established that MAP kinase plays a critical role in the transduction of various growth factor signals w x 45 . In fact, it is now generally accepted that 'MAP kinase' stands for 'mitogen activated protein kinase' instead of the original name, 'micro tubule-associated protein-2 kinase'. Therefore, it may not be surprising if the kinase in different cell types is stimulated, in ( )response to various stimuli, by different mechanisms including the well-known MAP kinase cascade inw x volving Ras, Raf-1, etc., 44,45 . While wortmannin is indeed a PI 3-kinase inhibitor, it is suggested that it is not as specific as it w x has been reported 54-56 . Thus, the results obtained in our present study with inhibitors do not positively prove that PDE kinase, MAP kinase and p70 S6K are localized downstream of PI 3-kinase. Nevertheless, we tentatively propose that insulin-dependent stimulation of all these three kinases is secondary to the activation of PI 3-kinase, since we obtained the same results from the experiments using structurally unrelated PI 3-kinase inhibitors, namely wortmannin and w x LY294002 14,52 . We further suggest that PDE kinase and MAP kinase or p70 S6K are associated with separate branches of the cascade of insulin action in adipocytes because the hormone-dependent stimulation of PDE kinase is not secondary to the activation of the latter two kinases. The branching point of the cascade may be found either at or below the level of PI 3-kinase.
In conclusion, our results indicate that PDE kinase may be a unique enzyme distinct from various other protein kinases, that the anti-lipolytic mechanism of insulin, including the hormone-sensitive PDE kinase, may be localized downstream of PI 3-kinase, and that MAP kinase may not be involved in the anti-lipolytic action of insulin in adipocytes.
